Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.
Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.
复制标题
新移民和旅行者评估(Asante)试验的监视和阿奇霉素治疗:设计和基线特征。
DOI:
10.1080/09286586.2016.1238947
复制
发表时间:
2016-12
影响因子:
1.8
通讯作者:
West SK
中科院分区:
文献类型:
--
作者:
Ervin AM;Mkocha H;Munoz B;Dreger K;Dize L;Gaydos C;Quinn TC;West SK
Immigrants and travelers may be sources of re-emergent infection in trachoma-endemic communities close to trachoma elimination. The primary objective of the A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) trial was to determine whether a newcomer and traveler surveillance and treatment program in addition to annual mass drug administration (MDA) would reduce Chlamydia trachomatis infection when compared to MDA alone. ASANTE was a randomized controlled trial in 52 communities in Kongwa, Tanzania. In 26 intervention communities, monitors treated everyone in new households, in-coming children and guardians in existing households, and all persons in households who had travelled between annual MDA events. 26 usual practice communities received MDA only. Surveys of 100 1-9-year-olds from each community were conducted at baseline and every 6 months up to 2 years to assess clinical trachoma and C trachomatis infection. Data on demographics and environmental factors were also collected. Mean prevalences of trachomatous inflammation - follicular (TF) and C trachomatis were equivalent between the two arms (5.2% and 3.7% in intervention, and 4.9% and 3.6% in usual practice communities, respectively). Of 318 children with TF, 36.5% tested positive for C trachomatis. TF prevalence was higher among households without a bicycle (P=0.03) and lower with increasing child’s age (P<0.001). Infection prevalence was higher among households >30 minutes from water (P=0.015). TF and infection prevalence decreased with increasing years of education (P=0.004 and P=0.002, respectively). The ASANTE trial will inform guidance on the surveillance and treatment of persons traveling or newly arriving to communities hypo-endemic for trachoma.